Brief: Predictive Oncology Expands The Application Of Its Live-Cell Tumor Platform
13/08/2024 12:11
Aug 13 (Reuters) - Predictive Oncology Inc POAI.O :
* PREDICTIVE ONCOLOGY EXPANDS THE APPLICATION OF ITS
LIVE-CELL
TUMOR PLATFORM TO DE-RISK DRUG DISCOVERY AND ACCELERATE PIPELINE
DEVELOPMENT
Source text for Eikon: ID:nGNX40JMsD
Further company coverage: POAI.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Axe Compute
See all newsBrief: Axe Compute Announces $25.9 Million In Contracts Across Two Long-Term Agreements
Brief: Axe Compute - Discloses Updated Risk Factors On Gpu Infrastructure Expansion - SEC Filing
Axe Compute Q1 revenue falls as legacy sales decline, net loss widens
NASDAQ RESUMED AT 09:48 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM